Department of Infectious Diseases and Microbiology, University of Pittsburgh Graduate School of Public Health, Pittsburgh, PA 15261, USA.
Immunol Invest. 2012;41(6-7):658-79. doi: 10.3109/08820139.2012.689591.
Myeloid derived suppressor cells (MDSCs) are a heterogeneous population of cells that inhibit anti-tumor immunity through a variety of mechanisms. Malignant gliomas are heavily infiltrated by myeloid cells, some of which appear to share biological functions of MDSCs. Our data with mouse de novo gliomas indicate critical roles of these cells in glioma development. This review summarizes the current understanding of MDSC biology in gliomas and discusses therapeutic interventions that can safely reverse the suppressive effects of MDSCs. The insight gained from these findings may lead to the development of novel immunotherapeutic strategies for gliomas.
髓系来源的抑制细胞(MDSCs)是一种异质性细胞群体,通过多种机制抑制抗肿瘤免疫。恶性神经胶质瘤被髓样细胞大量浸润,其中一些细胞似乎具有 MDSC 的生物学功能。我们用小鼠初发性神经胶质瘤的数据表明,这些细胞在神经胶质瘤的发展中起着关键作用。这篇综述总结了目前对神经胶质瘤中 MDSC 生物学的理解,并讨论了可以安全逆转 MDSC 抑制作用的治疗干预措施。从这些发现中获得的见解可能会导致开发用于神经胶质瘤的新型免疫治疗策略。